Gasmi Mehdi

CIK 00016148751 companyMENLO PARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001614875

Recent Transactions

50 trades

Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2021-05-12+40,000→ 40,000 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-07-20$4.80/sh+5,000→ 279,442 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-07-20$17.60/sh−5,000→ 274,442 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-07-20−5,000→ 78,000 total
Award
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-06-23+30,000→ 30,000 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-06-22$25.06/sh−23,605→ 274,442 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-06-22−23,605→ 83,000 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-06-22$4.80/sh+23,605→ 298,047 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-06-18−11,127→ 106,605 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-06-18$25.01/sh−11,127→ 274,442 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-06-18$4.80/sh+11,127→ 285,569 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-06-17$25.01/sh−268→ 274,442 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-06-17−268→ 117,732 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-06-17$4.80/sh+268→ 274,710 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-06-15$21.93/sh−1,416→ 278,026 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-06-15$23.00/sh−3,425→ 274,601 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-06-15$23.59/sh−159→ 274,442 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-06-15−10,000→ 118,000 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-06-15$4.80/sh+10,000→ 284,442 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-06-15$21.01/sh−5,000→ 279,442 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-05-21$4.80/sh+3,599→ 278,041 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-05-21−3,599→ 128,000 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-05-21$20.02/sh+3,599→ 274,442 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-05-20$20.01/sh−1,401→ 274,442 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-05-20−1,401→ 131,599 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-05-20$4.80/sh+1,401→ 275,843 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-05-18$19.03/sh−300→ 274,442 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-05-18−5,000→ 133,000 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-05-18$4.80/sh+5,000→ 279,442 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-05-18$18.11/sh−4,700→ 274,742 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-05-06$20.03/sh−25,000→ 274,442 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-05-06−25,000→ 138,000 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-05-06$4.80/sh+25,000→ 299,442 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-05-05−10,000→ 163,000 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-05-05$16.26/sh−10,000→ 274,442 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-05-05$4.80/sh+10,000→ 284,442 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-02-18+5,000→ 173,000 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-02-18$16.23/sh−5,000→ 258,979 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-02-18$4.80/sh+5,000→ 263,979 total
Tax Payment
Adverum Biotechnologies, Inc.
Common Stock
2020-02-12$11.33/sh−31,451→ 289,967 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-02-12−10,000→ 178,000 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-02-12$4.80/sh+10,000→ 284,442 total
Tax Payment
Adverum Biotechnologies, Inc.
Common Stock
2020-02-12$11.33/sh−31,482→ 289,936 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-02-12$15.07/sh−10,000→ 274,442 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Stock Option (Right to Buy)
2020-02-12−10,000→ 178,000 total
Tax Payment
Adverum Biotechnologies, Inc.
Common Stock
2020-02-12$15.05/sh−15,494→ 274,442 total
Tax Payment
Adverum Biotechnologies, Inc.
Common Stock
2020-02-12$15.05/sh−15,494→ 258,979 total
Exercise/Conversion
Adverum Biotechnologies, Inc.
Common Stock
2020-02-12$4.80/sh+10,000→ 268,979 total
Sale
Adverum Biotechnologies, Inc.
Common Stock
2020-02-12$15.07/sh−10,000→ 258,979 total
Tax Payment
Adverum Biotechnologies, Inc.
Common Stock
2020-02-09$10.24/sh−15,494→ 274,473 total

Companies

Adverum Biotechnologies, Inc.
VP, Pharmaceutical Development

Recent Filings

Address

C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A

MENLO PARK, CA, 94025

View on SEC.gov